Market News AIOpen the app

Conexeu Sciences is getting ready to submit Ten Minute Tissue™ to the FDA in early 2027.

TrialRead the original at otcmarkets.com
Good for CNXU

Conexeu produced scaled batches that met its internal standards, helping its path toward an FDA filing. The filing is still planned for Q1 2027, and wound and compatibility tests continue, so the product is not yet cleared.

CNXU · Conexeu Sciences Inc.

AI read · Good for CNXU

The AI's read

Meeting internal standards gives the company batches for regulatory testing and moves the product closer to a filing. But wound studies and compatibility tests continue, and FDA clearance is not reported. The manufacturing progress is favorable, though sales remain ahead.

Get alerts for CNXU

Follow Conexeu Sciences Inc. (CNXU) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CNXU
Free on the App Store and Google Play, or on the web.